The Next AI Investment Frontier: Decoding the 4 'Winning' Sectors in Seed/Early Stages

As the generative AI boom begins to settle, the focus of AI startup investment is steadily shifting toward the next wave.
While there was previously a series of large-scale investments in general-purpose AI models like ChatGPT and Anthropic, the current seed and early-stage focus has shifted to "industry-specific AI" and "automation of on-site tasks" as the new focal points.

Article:

According to data analysis from Crunchbase in the U.S., among AI-related startups that secured multi-million dollar funding in 2025, investment is particularly concentrated in the following four areas:
1. Back-office automation 2. Robotics 3. Healthcare AI tools 4. Drug discovery and medical research support AI
In this article, we will explain what is happening in each of these areas and why they are attracting capital.

1. Back-office automation: Reducing the 'invisible costs' of SMEs with AI

Back-office tasks such as accounting, payroll, and compliance are unavoidable burdens for any company. Especially for small and medium-sized enterprises (SMEs), the 'ratio of administrative costs' is extremely high because they cannot leverage economies of scale.

Against this backdrop, the largest number of companies appearing in 2025 AI seed investments are back-office automation startups.
Solutions that automatically process routine tasks such as accounting, HR, and legal work using generative AI and natural language processing are emerging one after another, aiming to 'ensure compliance while compressing labor costs.'

As a typical example, startups that automate invoice processing and companies providing AI accounting assistants are securing seed funding one after another.
Going forward, the integration of SME SaaS and AI backends will likely become a major trend.

2. Robotics: AI takes on 'Dull, Dirty, and Dangerous' labor

Wanting to leave 'Dull, Dirty, and Dangerous (3D)' tasks to robots—
this desire is being turned into reality by the fusion of AI and robotics.

Due to recent advancements in AI technology, robot perception, judgment, and behavioral control have improved dramatically.
Along with this, seed investments in the AI x robotics sector are surging.
AI robots are entering fields where automation was previously difficult, such as warehouse logistics, manufacturing, construction, and even agriculture.

According to Crunchbase data, more than a dozen companies raised multi-million dollar funding in 2025 alone.
Investors are clearly beginning to view the robotics industry as 'next-generation infrastructure.'

3. Medical AI tools: Reclaiming doctors' 'time'

Many medical professionals are losing more time to record-keeping and compliance tasks than to actual patient care.
The movement for AI to resolve this inefficiency is expanding rapidly.

Medical AI tools that automate electronic medical record entry, clinical record summarization, and insurance claim processing are appearing one after another. Medical AI tools are appearing one after another.
Many of these companies raised seed or early-stage funding in 2025.
The reason investors are paying attention to this field is clear.
" AI has the potential to increase productivity in medical settings tenfold"—this symbolizes the next wave of health-tech investment.

Startups are directly targeting reducing the workload of doctors, such as through medical record summarization AI using natural language processing and the automation of clinical support systems.
This area is expected to grow in the future while linking with government medical DX policies.

4. Drug discovery and medical research support: AI changes the 'speed of science'

The AI x biotech sector is also driving investment trends in 2025.
Particularly attracting attention is Lila Sciences in Cambridge, Massachusetts.
The company raised large-scale funding as a firm that accelerates research in life sciences, chemistry, and materials science with AI, promoting a 'scientific superintelligence platform.'

In drug discovery, AI is penetrating areas that require massive data processing, such as molecular structure analysis and drug candidate exploration.
It holds the potential to shorten to a matter of months research processes that previously took years.
In this field, besides Lila, more than 10 startups have secured early-stage funding, and an AI drug discovery ecosystem is beginning to form.

Conclusion: The 'second act' of AI investment is toward the automation of industrial tasks

The four fields introduced in this article—back office, robotics, healthcare, and drug discovery—are all "areas where AI removes societal friction."
Unlike the model development competition of the past, these fields are characterized by a shift toward 'vertical innovation' that solves industry-specific problems with AI.

How will these startups grow over the next few years and actually transform industry structures?
The next stage of AI investment is evolving from AI that dreams to AI that drives operations.

Recommended Articles

Next Big Wave (Growth Stocks, Seeds of Ideas, and Deep Dives into Trends)